A leading manufacturer of regenerative products in veterinary medicine has a new look and a fresh outlook. MediVet America of Nicholasville, Ky., this week changed its name to MediVet Biologics and updated its logo, mission and customer materials. The company, a subsidiary of Medical Australia, also launched the website www.medivetbiologics.com. “The rebranding reflects the many recent changes the company has undergone globally uniting the veterinary holdings of Medical Australia, which include MediVet America, TutaVet and MediVet Pty Ltd.,” the company announced. “The rebranding will also serve to better define the products and services offered by MediVet for the large and small animal market as well as its vision for the future.” Among MediVet Biologics’ products are adipose derived stem cell treatments, autologous conditioned serum (IRAP ACS) and platelet rich plasma (PRP), which is used for everything from soft tissue healing to hip dysplasia. The company has research projects underway involving scientists at the University of Kentucky, the University of Georgia and Kansas State University. Among the available therapies, in-clinic adipose derived stem cell treatments “have been very well received by the North American veterinary market,” CEO Jeremy Delk said. “[The treatments] have allowed us to assist animals as well as add brick-and-mortar value to veterinarian practices in a shifting and dynamic market,” Delk added.
